New thyroid test aims to cut unnecessary surgeries
NCT ID NCT07584447
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a genetic test called Thyroid GuidePx® can help doctors and patients with papillary thyroid cancer make better treatment choices. About 85 adults with early-stage thyroid cancer will take the test before surgery. Researchers will see if the test results change the planned treatment, such as reducing the need for total thyroid removal.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAPILLARY THYROID CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists mine 1,100 patient records to spot thyroid cancer return risks
- Robotic surgery through the mouth could eliminate neck scars in thyroid cancer patients
- AI assistant aims to ease thyroid cancer anxiety before surgery
- Real-Time tissue test may help surgeons avoid unnecessary neck dissections in thyroid cancer
- Hidden thyroid cancers: how common are they in patients with thyroiditis?
- Radioactive iodine: unnecessary for some thyroid cancer patients?